BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15918151)

  • 21. Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation.
    Willson JS; Godwin TD; Wiggins GA; Guilford PJ; McCall JL
    J Hepatol; 2013 Oct; 59(4):904-7. PubMed ID: 23707370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic use of cytokeratins, CD34, and neuronal cell adhesion molecule staining in focal nodular hyperplasia and hepatic adenoma.
    Ahmad I; Iyer A; Marginean CE; Yeh MM; Ferrell L; Qin L; Bifulco CB; Jain D
    Hum Pathol; 2009 May; 40(5):726-34. PubMed ID: 19157505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma.
    Yasui K; Hashimoto E; Komorizono Y; Koike K; Arii S; Imai Y; Shima T; Kanbara Y; Saibara T; Mori T; Kawata S; Uto H; Takami S; Sumida Y; Takamura T; Kawanaka M; Okanoue T;
    Clin Gastroenterol Hepatol; 2011 May; 9(5):428-33; quiz e50. PubMed ID: 21320639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma.
    Calderaro J; Letouzé E; Bayard Q; Boulai A; Renault V; Deleuze JF; Bestard O; Franco D; Zafrani ES; Nault JC; Moutschen M; Zucman-Rossi J
    N Engl J Med; 2018 Sep; 379(12):1178-1180. PubMed ID: 30231230
    [No Abstract]   [Full Text] [Related]  

  • 26. Nonalcoholic steatohepatitis and hepatocellular carcinoma: natural history?
    Cotrim HP; Paraná R; Braga E; Lyra L
    Am J Gastroenterol; 2000 Oct; 95(10):3018-9. PubMed ID: 11051414
    [No Abstract]   [Full Text] [Related]  

  • 27. Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas.
    Somorácz A; Tátrai P; Horváth G; Kiss A; Kupcsulik P; Kovalszky I; Schaff Z
    Hum Pathol; 2010 Sep; 41(9):1310-9. PubMed ID: 20471664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steatotic hepatocellular adenomas with different phenotypic subtypes: a case report.
    Alberti N; Castain C; Crombe A; Frulio N
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):e17-22. PubMed ID: 25260568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma.
    Bullock RE; Zaitoun AM; Aithal GP; Ryder SD; Beckingham IJ; Lobo DN
    J Hepatol; 2004 Oct; 41(4):685-6. PubMed ID: 15464253
    [No Abstract]   [Full Text] [Related]  

  • 30. The steatohepatitic variant of hepatocellular carcinoma and its association with underlying steatohepatitis.
    Salomao M; Remotti H; Vaughan R; Siegel AB; Lefkowitch JH; Moreira RK
    Hum Pathol; 2012 May; 43(5):737-46. PubMed ID: 22018903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two cases of non-alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis.
    Ichikawa T; Yanagi K; Motoyoshi Y; Hamasaki K; Nakao K; Toriyama K; Eguchi K
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1865-6. PubMed ID: 17074033
    [No Abstract]   [Full Text] [Related]  

  • 32. Argininosuccinate synthase 1 (ASS1): A marker of unclassified hepatocellular adenoma and high bleeding risk.
    Henriet E; Abou Hammoud A; Dupuy JW; Dartigues B; Ezzoukry Z; Dugot-Senant N; Leste-Lasserre T; Pallares-Lupon N; Nikolski M; Le Bail B; Blanc JF; Balabaud C; Bioulac-Sage P; Raymond AA; Saltel F
    Hepatology; 2017 Dec; 66(6):2016-2028. PubMed ID: 28646562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inflammatory Hepatic Adenoma].
    Lee JS; Jeong EK; Kim EK; An C; Kim HG; Kim SU; Han KH
    Korean J Gastroenterol; 2015 Jul; 66(1):59-63. PubMed ID: 26410896
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatocellular neoplasms arising in genetic metabolic disorders: steatosis is common in both the tumor and background liver.
    Cheng L; Jain D; Kakar S; Torbenson MS; Wu TT; Yeh MM
    Hum Pathol; 2021 Feb; 108():93-99. PubMed ID: 33245984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous rupture of a liver cell adenoma.
    Angunawela P; de Silva M
    Ceylon Med J; 1997 Mar; 42(1):42-3. PubMed ID: 9164033
    [No Abstract]   [Full Text] [Related]  

  • 36. The impact of obesity on liver histology.
    Goodman ZD
    Clin Liver Dis; 2014 Feb; 18(1):33-40. PubMed ID: 24274863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Malignant transformation of hepatocellular adenoma in men].
    Goudard Y; Rouquie D; Bertocchi C; Daligand H; Baton O; Lahutte M; Terris B; Baranger B
    Gastroenterol Clin Biol; 2010 Mar; 34(3):168-70. PubMed ID: 20189337
    [No Abstract]   [Full Text] [Related]  

  • 38. Pigmented hepatocellular adenoma with complete CD34 immunostaining pattern: a diagnostic dilemma.
    Vij M; Patra S; Rela M
    Indian J Pathol Microbiol; 2012; 55(4):528-30. PubMed ID: 23455796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is hepatocellular carcinoma part of the natural history of nonalcoholic steatohepatitis?
    Anagnostopoulos GK; Arvanitidis D; Tsiakos S; Margantinis G; Grigoriadis K; Kostopoulos P
    J Clin Gastroenterol; 2003 Jul; 37(1):88-9. PubMed ID: 12811221
    [No Abstract]   [Full Text] [Related]  

  • 40. Management of liver adenomatosis: results with a conservative surgical approach.
    Ribeiro A; Burgart LJ; Nagorney DM; Gores GJ
    Liver Transpl Surg; 1998 Sep; 4(5):388-98. PubMed ID: 9724476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.